Trial Profile
Evaluation of the mechanisms for castration-resistance using CRPC tissues to predict the efficacy of Enzalutamide
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Oct 2015
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics
- 14 Oct 2015 New trial record